
Chemical and Pharmaceutical Bulletin p. 928 - 938 (1999)
Update date:2022-07-30
Topics:
Shiota, Takeshi
Yamamori, Teruo
Sakai, Katsunori
Kiyokawa, Mitsugu
Honma, Tsunetoshi
Ogawa, Masayoshi
Hayashi, Kunio
Ishizuka, Natsuki
Matsumura, Ken-Ichi
Hara, Mariko
Fujimoto, Masafumi
Kawabata, Tomoji
Nakajima, Shigeyuki
We have already reported 7-oxo-4,7-dihydropyrazolo[1,5-α]pyrimidine-3- carboxylic acid derivatives, which are potent in vitro angiotensin II (AII) antagonists, but have no oral antihypertensive activity. Removal of the carboxylic acid and replacement of t
View MoreHunan Dinuo Pharmaceutical Co.,Ltd.
Contact:86-731-88280100*8561
Address:Bio-pharmaceutical industrial park, Liuyang, Hunan, China
Taizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Forsman Scientific(Beijing)co.,Ltd.
Contact:+86-10-64646565
Address:Rm No.1301, Building-2, No. A-13 Beiyuan Road, Chaoyang District Beijing, China, PR,
Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Contact:86-371-55219111
Address:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI,CHINA
Doi:10.1002/recl.19871060401
(1987)Doi:10.1016/S0040-4020(01)81669-0
(1987)Doi:10.1021/ol802828d
(2009)Doi:10.1016/j.jfluchem.2008.04.003
(2008)Doi:10.1007/s10600-008-9126-8
(2008)Doi:10.3390/molecules16086634
(2011)